
Maureen Leehey, M.D., '86, is a neurologist specializing in movement disorders at the University of Colorado Health Science Center in Denver where she has been since completing her residency and fellowship. She is married to Aubrey Dobbs, M.D., an internist, and they have two daughters, Courtney, 11, and Katie, 9. Dr. Leehey's passion is researching a genetic disorder known as fragile X-associated tremor/ataxia syndrome or FXTAS.

What is FXTAS?
FXTAS is a neurodegenerative disorder that
occurs in carriers of a ‘premutation' in the
fragile X mental retardation 1 (FMR1) gene.
FMR1 normally has a region that consists of
three nucleotides (CGG) that is repeated five
to 40 times, but when the CGG is repeated
55 to 200 times, it is called a premutation.
Premutation carriers have been thought
to be asymptomatic until recently, when
it was found that 20 percent of women
develop early menopause and, very recently,
when my colleagues and I found that men
over age 50 are at high risk of developing
FXTAS. Women may also develop FXTAS,
but it is much less common. Affected
persons have progressive ataxia, tremor, and
cognitive dysfunction. Ataxia, balance, and
incoordination are the major symptoms.
Since this disorder has only recently been
described, many physicians do not recognize
it and give affected persons other diagnoses
such as Parkinson's disease, essential tremor,
dementia, or stroke. Often they are told
their symptoms are simply due to aging.
FXTAS affects about one in 8,000 men over
age 50, is a common cause of ataxia, and it's
prevalence appears to be similar to that of
other neurodegenerative disorders such as
parkinsonism plus, spinocerebellar ataxia,
and ALS (Lou Gehrig's disease).
How is FXTAS inherited?
Usually what happens is a child is born with
fragile X syndrome, which is caused by a
‘full mutation' in FMR1, meaning the CGG
is repeated greater than 200 times. Fragile X
syndrome – a very different disorder from
FXTAS – is a neurodevelopmental disorder
and a common cause of mental retardation,
severe behavioral problems, and autism. The
mother is a premutation carrier and inherited
the premutation from her mother or father.
These grandparents of the child with fragile
X syndrome, however, are usually unaware
they are carriers. If persons with FXTAS
were identified more readily, then families
could receive proper genetic counseling to
understand their risks. Unfortunately, many
families have more than one child with
fragile X syndrome before the disorder is
recognized.
Is there a cure for FXTAS?
No, but there are medications that are
effective in treating some of the symptoms.
How did you become interested in
researching this disorder?
I work with a developmental pediatrician,
Randi Hagerman, M.D., who is an expert on
fragile X syndrome. She and I were working
together at the University of Colorado in
1998 when she noticed that the moms of
fragile X children would often report that
one of their parents had Parkinson's disease,
tremor, or balance difficulties. So, Randi sent
some of these grandparents to me, since I'm
a movement disorders neurologist. All were
premutation carriers over age 50, and all
had a unique syndrome that had not been
described before.
Has your research on FXTAS been
published?
Yes. We published in 2001 in Neurology.
The article generated a lot of attention. One
reason that this syndrome is important is
because it brought attention to a pathogenic
mechanism that's just now being better
understood. This mechanism, called
messenger RNA toxicity, causes another
neurodegenerative disorder, myotonic
dystrophy. We believe RNA toxicity is a
major cause of FXTAS and perhaps of other
disorders. Research on this new mechanism
will help combat neurodegeneration in the
elderly population.
In this day and age, it is an exciting and unique opportunity to be able to describe a new neurological syndrome. Since our discovery, our research group has been able to examine over 100 affected persons. This has enabled us to publish findings on the clinical and autopsy signs, prevalence, natural history of FXTAS, and its cause.
Do you have other research interests?
Yes, I am also involved in a number of clinical
trials on Parkinson's disease. As a lead
investigator in the Parkinson Study Group, I
try to help in the international effort to find
a way to slow down the disorder.
Why did you decide to attend medical
school?
I had earned a B.S. from the UT-Houston
nursing school and had worked as a nurse for
about five years. I would often ask physicians
questions but would not fully understand
their answers. So, I decided it would be fun
to go to medical school. However, my grades
when I graduated from nursing school had
not been the best. While working as a nurse
at Hermann Hospital, I met Dr. "Red" Duke.
He was really nice to the nurses. I talked
with him about what I could do to get into
medical school. He gave me advice, I followed
it, and with his support and my family's, I
was able to get accepted into the UT-Houston
Medical School. Our medical school class
was interesting because the average age of
students was older. I was one of the many
who had a prior career. Also, our medical
school class was one of the first that had
more females than was traditional back in
those days.
At what point in your medical school
career did you know that you wanted
to specialize in neurology?
It wasn't until my last year as a medical
student. It was hard for me to pin it down.
I thought, ‘What specialty would be a nice
lifestyle for a woman that would allow me to
have a family and some free time but would
also be fun and intellectually challenging?'
I considered ophthalmology and dermatology, but at the beginning of my fourth year, I did a rotation in neurology. I had so much fun on that rotation. Also, it was always clear to me without even thinking about it that the brain was the most important part of the body. If the brain isn't working, then life isn't worthwhile. Thus, I decided when I was partway through my fourth year to switch to neurology. I called Dr. Jim Grotta in the neurology department for advice, and he recommended some places to go interview. I quickly sent out applications for neurology. While neurology has always been the right choice for me, I have found that juggling an academic career and family life can at times be a real strain.
How did medical school prepare you
for your current position?
I found that UT-Houston provided a lot of
exposure to the many different options to
focus your career on. The rotations were set
up so that we would do general medicine
and surgery early in the third year, and at
the same time, we were exposed to medical
and surgical subspecialties. Then you could
choose rotations of interest. Also, throughout
my four years of study, the school seemed to
have a lot of layers of help. No matter what
your problem was, you knew you could go
somewhere to get help. Further, the faculty
in general were easily available for help and
advice. One thing that was missing in our
curriculum, however, was classes on how to
handle your money once you started making
some.
Do you have any fond memories from
Medical School?
Oh yes – many. One thing I particularly
enjoyed was the dance parties on Friday
nights in the cafeteria. I would stay in the
LRC (the library) to study until about 9
p.m. and then walk over to the party. The
parties were for medical students, and many
residents would attend also. I have many
other fond memories also of just interacting
with my colleagues at the school and outside
of school. The Freshman Retreat at the
beginning of the year was a great way to get
to know your class.
The latest issue is available here in PDF format. (NOTE: 55meg file)
Please send us your news & photos for CLASS NOTES.
The UT-Houston Medicine Magazine is produced by the Office of Communications for alumni, faculty, and friends of The University of Texas Medical School at Houston. To advertise with us, please download the advertising information PDF.